Across GLP-1 trials, about 60% of lost weight returns within the first year and roughly 75% returns over the longer curve, with the fastest regain in the early months. In semaglutides extension, about two-thirds returned within one year. The pattern reflects removal of appetite suppression after major weight loss
At $249 to $297 per month through Direct Meds, long-term use costs $3,000 to $3,600 per year
Neurodegenerative Diseases : Preliminary research is examining semaglutides neuroprotective properties, including potential benefits for conditions like Alzheimers disease, due to its effects on inflammation and metabolic pathways in the brain Research Findings Semaglutide for Weight Loss Semaglutide is a long-acting GLP-1 receptor agonist that allows for once-weekly subcutaneous administration and has been approved by both the EMA and FDA for the treatment of type 2 diabetes
Weight Loss Support, Personalized to You SkinnyRx connects you with a licensed provider who can assess your eligibility, prescribe GLP-1 treatment when appropriate, and support you with ongoing guidance throughout your weight loss journey
